510(k) Report

510(k) · Cleared

Recalled · Class II · 2013

Stryker Injectable Cement

K060763510(k) TraditionalCleared Sep 22, 2006185-day reviewClass II21 CFR 882.5300Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Stryker · GXP Methyl Methacrylate For Cranioplasty

Cleared on Sep 22, 2006 as substantially equivalent to K060061 (Stryker Corp., 2006) and 1 other predicate after a 185-day review. Its family tree reaches back 8 generations to 1987. 8 later devices descend from it. It has been recalled once.

Decided
Sep 22, 2006
Review
185 days
Class
Class II
Product code
GXP
Recalls
1
Predicates
2

Its longest line of descent runs back 8 generations to K873689 (1987). 18 ancestors in all, the oldest K861369 (1986). 8 later devices descend from it, 5 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2003: 1 other ancestor2002: 1 other ancestor2001: 2 other ancestors1999: 1 other ancestor1986: 1 other ancestor1997: 2 other ancestors1992: 1 other ancestor2024: 2 descendants cleared2023: 2 descendants cleared2015: 1 descendant cleared2026: 3 descendants clearedK873689 · Cranioplastic, Acrylic Cranioplasty Material · Dentsply Intl. · 1987K953339 · Bonesource Hydroxyapatite Cement (Hac) · Osteogenics, Inc. · 1996K973789 · Norian Cranial Repair System (CRS)Bone Cement- 5CC Kit, Norian Cranial Repair System (CRS) Bone Cement- 10CC · Norian Corp. · 1998K991398 · Bonesource Hydroxyapatite Cement (Hac) Expanded Kit · Stryker Leibinger · 1999K021440 · Bonesource Hac · Stryker Instruments · 2002K032366 · Bonesource Hac Fast Setting Cement · Stryker Instruments · 2003K043334 · Bone Source Hac Rapid Setting Cement · Stryker Instruments · 2005K060061 · Stryker Injectable Cement · Stryker Corp. · 20061990200020102020
  1. Root · 8 generations backK873689 Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl. · 1987
  2. 7 generations backK953339 Bonesource Hydroxyapatite Cement (Hac)Osteogenics, Inc. · 1996
  3. 6 generations backK973789 Norian Cranial Repair System (CRS)Bone Cement- 5CC Kit, Norian…Norian Corp. · 1998
  4. 5 generations backK991398 Bonesource Hydroxyapatite Cement (Hac) Expanded KitStryker Leibinger · 1999
  5. 4 generations backK021440 Bonesource HacStryker Instruments · 2002
  6. 3 generations backK032366 Bonesource Hac Fast Setting CementStryker Instruments · 2003
  7. 2 generations backK043334 Bone Source Hac Rapid Setting CementStryker Instruments · 2005
  8. 1 generation backK060061 Stryker Injectable CementStryker Corp. · 2006
  9. This deviceK060763 Stryker Injectable CementStryker · 2006
  10. Descendant · cites it directly · 2 of its ownK241027 Permatage Settable Bone PuttyOrthocon, Inc. · 2024
  11. Descendant · cites it directly · 1 of its ownK221933 MONTAGE Settable, Resorbable Bone PuttyOrthocon, Inc. · 2023
  12. Descendant · 2 generations on · 0 of its ownK261265 Permatage XT Settable Bone PuttyOrthocon, Inc. · 2026
  13. Descendant · 2 generations on · 0 of its ownK253732 Permatage Flowable, Settable Bone PasteOrthocon, Inc. · 2026
  14. Descendant · 2 generations on · 0 of its ownK253854 MONTAGE XT Cranial CementOrthocon, Inc. · 2026

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2015: 12023: 22024: 22026: 3
2015high 3 (2026) · low 0 (2016)2026

Most influential descendants

Showing 5 of 8 · See all
  • K241027Permatage Settable Bone PuttyOrthocon, Inc. · 2024 · cites it directly2descendants
  • K221933MONTAGE Settable, Resorbable Bone PuttyOrthocon, Inc. · 2023 · cites it directly1descendant
  • K261265Permatage XT Settable Bone PuttyOrthocon, Inc. · 2026 · 2 generations on0descendants
  • K253732Permatage Flowable, Settable Bone PasteOrthocon, Inc. · 2026 · 2 generations on0descendants
  • K253854MONTAGE XT Cranial CementOrthocon, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K873689Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl.1987—
−7K953339Bonesource Hydroxyapatite Cement (Hac)Osteogenics, Inc.1996—
−6K973789Norian Cranial Repair System (CRS)Bone Cement- 5CC Kit, Norian Cranial Repair…Norian Corp.1998—
−5K991398Bonesource Hydroxyapatite Cement (Hac) Expanded KitStryker Leibinger1999—
−4K021440Bonesource HacStryker Instruments2002—
−3K032366Bonesource Hac Fast Setting CementStryker Instruments2003—
−2K043334Bone Source Hac Rapid Setting CementStryker Instruments2005—
−1K060061Stryker Injectable CementStryker Corp.2006—
0 (this device)K060763Stryker Injectable CementStryker2006—
+1K241027Permatage Settable Bone PuttyOrthocon, Inc.2024—
+1K221933MONTAGE Settable, Resorbable Bone PuttyOrthocon, Inc.2023—
+2K261265Permatage XT Settable Bone PuttyOrthocon, Inc.2026—
+2K253732Permatage Flowable, Settable Bone PasteOrthocon, Inc.2026—
+2K253854MONTAGE XT Cranial CementOrthocon, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199210
199720
199910
200120
200210
200310
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
202320
202420
202630
FIG. 1 — Lineage of K060763, 1987–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXP device

  1. #1 K241027 Permatage Settable Bone Puttyscore 16.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K060061Stryker Injectable Cement
Summary page 1
…oration of bony contour in the craniofacial skeleton. Substantial Equivalency Information Stryker® Injectable Cement is substantially equivalent to legally marketed K060061 Stryker® Injectable Cement and K043334 Stryker® HAC Rapid Set Cement. DEPARTMENT OF HEALTH & HUMAN SERVICE…
Stryker Corp.2006—
*K043334Bone Source Hac Rapid Setting Cement
Summary page 1
…cial skeleton. Substantial Equivalency Information Stryker® Injectable Cement is substantially equivalent to legally marketed K060061 Stryker® Injectable Cement and K043334 Stryker® HAC Rapid Set Cement. DEPARTMENT OF HEALTH & HUMAN SERVICES…
Stryker Instruments2005—

Also cleared against K060061: 6 other devices →

What descends from it? (8)

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241027Permatage Settable Bone PuttyOrthocon, Inc.20242
K221933MONTAGE Settable, Resorbable Bone PuttyOrthocon, Inc.20231
K232771Montage Flowable Settable, Resorbable Bone PasteOrthocon, Inc.20240
K231475MONTAGE-QS Settable, Resorbable Bone PuttyOrthocon, Inc.20230
K143661DirectInjectStryker20150

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 30, 2013Class IIZ-2054-2013Package design/selectionStryker received reports of the desiccant bag in the kit leaking silica gel granulate. This could increase exposure to anesthesia during surgical delay up to 60 minutes or inadvertent implantation of silica gel granulate which could cause…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 7 companies; a new generation was cleared every 1.3 years on median.
  • 1 of the 18 ancestors has a recall of any class.
  • Of its descendants, K241027 (Orthocon, Inc., 2024) has gone furthest, with 2 descendants of its own.
  • 6 other devices also cite its predicate K060061.

How does its category compare?

All GXP devices

GXP Methyl Methacrylate For Cranioplasty: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GXP

4so far in 2026, the most since 2007

2007: 32009: 12010: 12015: 12017: 12019: 12023: 22024: 22026 (partial year): 4
2007high 4 (2026) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXP

87in 2007

2007: 87 days median2026 (partial year): 85 days median
2007high 87 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXP

2in 2019

2009: 12011: 12012: 12019: 2
2007high 2 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXP

1in 2025

2007: 82008: 102009: 222010: 592011: 312012: 282013: 182014: 192015: 132016: 172017: 162018: 92019: 92020: 312021: 142022: 32023: 22024: 102025: 1
2007high 59 (2010) · low 1 (2025)2025

MAUDE reports naming product code GXP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200738708
20080—010
20091—122
20101—059
20110—131
20120—128
20130—018
20140—019
20151—013
20160—017
20171—016
20180—09
20191—29
20200—031
20210—014
20220—03
20232—02
20242—010
20250—01
20264850—

What is it indicated for?

Stryker® Injectable Cement is a self-setting calcium phosphate cement indicated to fill bony voids or gaps of the skeletal system (i.e. extremitiers-rariiotaiii, sgyiit,;.aid pcevis). These defects may be surgically created or osseous defects created from traumatic injury to the bone. The Stryker Injectable Cement is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. Stryker® Injectable Cement cured in…

Read the full statement (155 words)

Stryker® Injectable Cement is a self-setting calcium phosphate cement indicated to fill bony voids or gaps of the skeletal system (i.e. extremitiers-rariiotaiii, sgyiit,;.aid pcevis). These defects may be surgically created or osseous defects created from traumatic injury to the bone. The Stryker Injectable Cement is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure.

Stryker® Injectable Cement cured in situ provides an open void/gap filler that call augment provisional hardware (e.g., K-Wires, plates, screws) to help support bone fragments during the surgical procedure. The cured cement acts only as a temporary support media and is not intended to provide structural support during the healing process.

Stryker® Injectable Cement is a self-setting, calcium phosphate cement intended for use in the repair of neurosurgical burr holes, contiguous craniotomy cuts and other cranial defects as well as in the augmentation or restoration of bony contour in the craniofacial skeleton.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060763: Stryker Injectable Cement.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K060763

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026